DOCSLIB.ORG

Comparison of Nutritional Deficiencies and Complications Following Vertical Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Bi

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Comparison of Nutritional Deficiencies and Complications Following Vertical Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Bi COMPARISON OF NUTRITIONAL DEFICIENCIES AND COMPLICATIONS FOLLOWING VERTICAL SLEEVE GASTRECTOMY, ROUX-EN-Y GASTRIC BYPASS, AND BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH Kinsy Miller A Thesis Submitted to the graduate college of Bowling Green State University in partial fulfillment of the requirements for the degree of MASTER OF FAMILY CONSUMER SCIENCE August 2009 Committee: Martha Sue Houston, Advisor Rebecca Pobocik Priscilla Coleman ii ABSTRACT Martha Sue Houston, Advisor Background: The prevalence of morbid obesity continues to increase and bariatric surgery remains the superior way to treat morbid obesity and related disorders. Although bariatric surgery can produce significant weight loss and alleviate comorbidities, it can also impact nutritional status in ways that have not been adequately studied. Objective: The objective of the present study was to compare the incidence of nutritional deficiencies, significant complications, and amount of weight loss in patients undergoing three different bariatric surgery procedures: Vertical Sleeve Gastrectomy (VSG); Roux-en-y Gastric Bypass (RNY-GB); and Biliopancreatic Diversion with Duodenal Switch (BPD-DS). In addition, the role of the registered dietitian (RD) in the outcome of bariatric patients was explored. Design: A review of all patients undergoing bariatric surgery between April 2006 and December 2007 (n = 119) was conducted from prospectively maintained medical records of a single bariatric surgery practice. Laboratory data related to specific nutrients, hyperlipidemia, and anemia, concerns about compliance with nutrient supplement intake and dietary protein intake, and complication and post-surgery hospitalization rates were compared among patients undergoing the three surgical procedures, VSG, RNY-GB, and BPD-DS. Patients were followed for a minimum of 6 months and a maximum of 18 months after surgery. Results: Vitamin B12 and calcium deficiency were uncommon after surgery at 1.2% and 2.6%, respectively, among recipients of all surgery types (p = 0.506, and p = 0.092, respectively). The overall rate of folate deficiency was 7.2% and the rate of BPD-DS patients developing folate deficiency after surgery was 37.5% (p = 0.002). The overall rate of anemia was 33.8% and the iii rate of RNY-GB patients developing anemia following surgery was 50% (p = 0.010). Vitamin D deficiency was markedly high at 66.7% of all patients. All of the BPD-DS patients developed deficiency, which was significantly higher than the other groups (p = 0.003). Protein and vitamin A deficiency were present in 38% and 34.8% of all patients, respectively, but there were no significant differences among surgery types (p = 0.216, and p = 0.141, respectively). Patients who were documented as non-compliant with multivitamin/mineral intake were more likely to develop anemia (p = 0.015) and those who were documented as non-compliant with calcium supplements were more likely to develop vitamin D deficiency (p = 0.022). Weight loss over time among all surgery types was significantly different (p < 0.0001). At 12 months after surgery average percent excess body weight loss (EBWL) was 70.9% for BPD-DS, 59.7% for RNY-GB and 40.2% for VSG. There were no significant differences across groups in the risk of developing complications after surgery relative to weight loss (p = 0.079). Lower albumin levels following surgery were correlated with more complications (r = - 0.31, p = 0.008). RD visits were positively correlated with higher minimum albumin levels (r = 0.24, p=0.025) and greater %EBWL (r = 0.30, p = 0.002). Conclusions: Nutritional deficiencies and anemia occurred as a result of all bariatic surgery procedures, both restrictive (VSG) and malabsorptive procedures (RNY-GB and BPD-DS) in the 18 months post-surgery. The incidence of vitamin D deficiency (66.7%) was particularly concerning. Patient intake of recommended levels of nutrient supplements and dietary protein was poor and was related to some of the nutrient deficiencies and anemia. RD visits were beneficial as more RD visits were related to greater weight loss and higher albumin levels following surgery. Increased RD visits and monitoring of nutritional status, nutrient supplement intake and dietary intake of patients pre and post-bariatric surgery is warranted. iv ACKNOWLEDGMENTS I would like to acknowledge my advisor, Dr. Sue Houston, for all of the hours and work put in to this project. In addition, I would like to acknowledge my thesis committee members Dr. Rebecca Pobocik and Dr. Priscilla Coleman for their time and efforts in putting this thesis together. Finally, a thank you to the Bowling Green State University Statistical Lab for all of their hours devoted to analyzing the data presented in this study. v TABLE OF CONTENTS Page CHAPTER I. INTRODUCTION TO OBESITY ............................................................... 1 CHAPTER II. LITERATURE REVIEW........................................................................... 4 Introduction to Bariatric Surgeries......................................................................... 4 Normal Digestion and Absorption ......................................................................... 7 Nutritional Deficiencies......................................................................................... 8 Comparison of Nutritional Deficiencies Following Bariatric Surgeries .................. 11 STATEMENT OF THE PROBLEM................................................................................. 13 RESEARCH QUESTIONS............................................................................................... 14 CHAPTER III. METHODS.............................................................................................. 15 Nutritional Counseling .......................................................................................... 16 Indicators of Nutritional Status.............................................................................. 20 STATISTCAL METHODS............................................................................................... 23 CHAPTER IV. RESULTS ................................................................................................ 24 CHAPTER V. DISCUSSION ........................................................................................... 51 REFERENCES ......... ....................................................................................................... 58 vi LIST OF FIGURES/TABLES Figure/Table Page 1 Anatomy of roux-en-y........................................................................................ 4 2 Anatomy of biliopancreatic diversion with duodenal switch .................................. 5 3 Anatomy of vertical sleeve gastrectomy ................................................................ 6 1 Summary of protein, iron, vitamin B12, calcium, and vitamin D deficiency (% of subjects) following various bariatric surgeries.............................................. 10 2 Number of patients undergoing medically supervised weight loss for 3 or 6 months per type of surgery performed .................................................................... 16 3 Foods included in full and clear liquid diet prior to surgery .................................... 17 4 Vitamin, mineral, and protein recommendations per type of bariatric surgery at 0-1 months and 3 + months post-operatively.......................................................... 17 5 Protein requirements following bariaric surgery per diet phase .............................. 18 6 Optisource™ chewable vitamin and mineral supplement ........................................ 18 7 Nutrition parameters studied and laboratory data available during the study perioda ……………… ........................................................................................... 20 8 Pre-operative characteristics of subjects by surgery typea....................................... 24 9 Evidence of nutritional deficiencies pre and post-surgery ...................................... 26 10 Evidence of iron-related nutritional deficiencies pre-and post-surgery ................... 33 11 Evidence of cholesterol related abnormalities pre-and post-surgery a,b .................... 36 12 Documented concerns regarding adequacy of patient intake of multi-vitamin mineral supplements, calcium supplements, vitamin A & D supplements, and protein dietary intake after bariatric surgery........................................................... 37 vii LIST OF FIGURES/TABLES, CONT. Figure/Table Page 13 Difference in nutritional deficiencies among patients categorized by documented concerns regarding multivitamin mineral supplement and protein intake following bariatric surgery ..................................................................................................... 38 14 Differences in nutritional deficiencies related to compliance with calcium supplementation .................................................................................................... 41 15 Comparison study of weight loss ........................................................................... 43 4 Differences in pounds lost over time among the 3 different surgery types.............. 44 5 Differences in Percent Excess Body Weight Loss (%EBWL) over time among the 3 different surgery types........................................................................................ 45 16 Complications following bariatric surgery a ........................................................... 46 1 CHAPTER
Load more

Recommended publications
  • Recent Insights Into the Role of Vitamin B12 and Vitamin D Upon Cardiovascular Mortality: a Systematic Review
    Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423) Volume 2 Issue 12 December 2018 Review Article Recent Insights into the Role of Vitamin B12 and Vitamin D upon Cardiovascular Mortality: A Systematic Review Raja Chakraverty1 and Pranabesh Chakraborty2* 1Assistant Professor, Bengal School of Technology (A College of Pharmacy), Sugandha, Hooghly, West Bengal, India 2Director (Academic), Bengal School of Technology (A College of Pharmacy),Sugandha, Hooghly, West Bengal, India *Corresponding Author: Pranabesh Chakraborty, Director (Academic), Bengal School of Technology (A College of Pharmacy), Sugandha, Hooghly, West Bengal, India. Received: October 17, 2018; Published: November 22, 2018 Abstract since the pathogenesis of several chronic diseases have been attributed to low concentrations of this vitamin. The present study Vitamin B12 and Vitamin D insufficiency has been observed worldwide at all stages of life. It is a major public health problem, throws light on the causal association of Vitamin B12 to cardiovascular disorders. Several evidences suggested that vitamin D has an effect in cardiovascular diseases thereby reducing the risk. It may happen in case of gene regulation and gene expression the vitamin D receptors in various cells helps in regulation of blood pressure (through renin-angiotensin system), and henceforth modulating the cell growth and proliferation which includes vascular smooth muscle cells and cardiomyocytes functioning. The present review article is based on identifying correct mechanisms and relationships between Vitamin D and such diseases that could be important in future understanding in patient and healthcare policies. There is some reported literature about the causative association between disease (CAD). Numerous retrospective and prospective studies have revealed a consistent, independent relationship of mild hyper- Vitamin B12 deficiency and homocysteinemia, or its role in the development of atherosclerosis and other groups of Coronary artery homocysteinemia with cardiovascular disease and all-cause mortality.
    [Show full text]
  • Family Practice
    THE JOURNAL OF FAMILY PRACTICE Emmanuel Andrès, MD, B12 deficiency: A look beyond Laure Federici, MD, Stéphan Affenberger, MD pernicious anemia Department of Internal Medicine, Diabetes and Metabolic Diseases, Food-B12 malabsorption—not pernicious anemia—is the Hôpitaux Universitaires de Strasbourg, leading cause of B12 malabsorption. It’s also very subtle Strasbourg, France emmanuel.andres @chru-strasbourg.fr Practice recommendations such as its link to Helicobacter pylori • Mild, preclinical B deficiency infection and long-term antacid and bi- Josep Vidal-Alaball, MD 12 Department of General is associated with food-B12 guanide use. It also requires that you Practice, Cardiff University, malabsorption more often than consider not only a patient’s serum B12 United Kingdom with pernicious anemia. (C) ® Dowdenlevels, but his Health homocysteine Media and meth - Noureddine Henoun ylmalonic acid levels, since they are con- Loukili, PhD • The classic treatment for B 12 Department of Hygiene and deficiency—particularly when the sidered more sensitive indicators of co- 6 Fight against Nosocomial cause is not a dietaryCopyright deficiency—isFor personalbalamin deficiency. use Keyingonly in on these Infections, Hôpital Calmette, 100 to 1000 mcg per month of indicators early will ensure prompt treat- CHRU de Lille, Lille, France cyanocobalamin, IM. (B) ment, which typically includes intramus- cular injections of the vitamin, but which Jacques Zimmer, MD, PhD • Oral crystalline cyanocobalamin could revolve around a more convenient Laboratoire is an effective treatment for food- d’Immunogénétique- option: oral B12. Allergologie, Centre de B12 malabsorption, though it’s Recherche Public de la Santé effectiveness in the long term has (CRP-Santé) de Luxembourg, not been demonstrated.
    [Show full text]
  • Nutrition 102 – Class 3
    Nutrition 102 – Class 3 Angel Woolever, RD, CD 1 Nutrition 102 “Introduction to Human Nutrition” second edition Edited by Michael J. Gibney, Susan A. Lanham-New, Aedin Cassidy, and Hester H. Vorster May be purchased online but is not required for the class. 2 Technical Difficulties Contact: Erin Deichman 574.753.1706 [email protected] 3 Questions You may raise your hand and type your question. All questions will be answered at the end of the webinar to save time. 4 Review from Last Week Vitamins E, K, and C What it is Source Function Requirement Absorption Deficiency Toxicity Non-essential compounds Bioflavonoids: Carnitine, Choline, Inositol, Taurine, and Ubiquinone Phytoceuticals 5 Priorities for Today’s Session B Vitamins What they are Source Function Requirement Absorption Deficiency Toxicity 6 7 What Is Vitamin B1 First B Vitamin to be discovered 8 Vitamin B1 Sources Pork – rich source Potatoes Whole-grain cereals Meat Fish 9 Functions of Vitamin B1 Converts carbohydrates into glucose for energy metabolism Strengthens immune system Improves body’s ability to withstand stressful conditions 10 Thiamine Requirements Groups: RDA (mg/day): Infants 0.4 Children 0.7-1.2 Males 1.5 Females 1 Pregnancy 2 Lactation 2 11 Thiamine Absorption Absorbed in the duodenum and proximal jejunum Alcoholics are especially susceptible to thiamine deficiency Excreted in urine, diuresis, and sweat Little storage of thiamine in the body 12 Barriers to Thiamine Absorption Lost into cooking water Unstable to light Exposure to sunlight Destroyed
    [Show full text]
  • Guidelines on Food Fortification with Micronutrients
    GUIDELINES ON FOOD FORTIFICATION FORTIFICATION FOOD ON GUIDELINES Interest in micronutrient malnutrition has increased greatly over the last few MICRONUTRIENTS WITH years. One of the main reasons is the realization that micronutrient malnutrition contributes substantially to the global burden of disease. Furthermore, although micronutrient malnutrition is more frequent and severe in the developing world and among disadvantaged populations, it also represents a public health problem in some industrialized countries. Measures to correct micronutrient deficiencies aim at ensuring consumption of a balanced diet that is adequate in every nutrient. Unfortunately, this is far from being achieved everywhere since it requires universal access to adequate food and appropriate dietary habits. Food fortification has the dual advantage of being able to deliver nutrients to large segments of the population without requiring radical changes in food consumption patterns. Drawing on several recent high quality publications and programme experience on the subject, information on food fortification has been critically analysed and then translated into scientifically sound guidelines for application in the field. The main purpose of these guidelines is to assist countries in the design and implementation of appropriate food fortification programmes. They are intended to be a resource for governments and agencies that are currently implementing or considering food fortification, and a source of information for scientists, technologists and the food industry. The guidelines are written from a nutrition and public health perspective, to provide practical guidance on how food fortification should be implemented, monitored and evaluated. They are primarily intended for nutrition-related public health programme managers, but should also be useful to all those working to control micronutrient malnutrition, including the food industry.
    [Show full text]
  • בדודקה BEDODEKA ------להזרקה לתוך השריר או מתחת לעור Solution for I.M
    "פורמט עלון זה נקבע ע"י משרד הבריאות ותוכנו נבדק ואושר". עלון מאושר: מאי 2011. “This leaflet format has been determined by the Ministry of Health and the content thereof has been checked and approved.” Date of approval: May 2011. עלון לרופא Physician's Package Insert ========================================================================== בדודקה BEDODEKA --------------------------------------------------------------------- להזרקה לתוך השריר או מתחת לעור Solution for I.M. or S.C. Injection Composition Each ampoule of 1 ml contains: Active Ingredient Cyanocobalamin (vitamin B12) 1000 micrograms/ml Other Ingredients Sodium acetate anhydrous, acetic acid glacial, water for injection. Mechanism of Action Vitamin B12 (cyanocobalamin) is essential for growth, cell reproduction, hematopoiesis, and nucleoprotein and myelin synthesis. It has many metabolic interrelationships with the basic nutrients. Its physiological role is associated with methylation, participating in nucleic acid and protein synthesis. Vitamin B12 (cyanocobalamin) is essential for folate utilization with functional folate deficiency resulting from its absence. Indications Pernicious anemia and its neurological complication, subacute combined degeneration of the spinal cord. Treatment of vitamin B12 deficiency states and macrocytic anemias associated with nutritional deficiencies, gastrectomy and abnormalities of, or malabsorption from, the gastrointestinal tract such as celiac disease, sprue and accompanying folic acid deficiency. Bedodeka is also suitable for use as the flushing dose in the Schilling Test for pernicious anemia. Contraindications Known hypersensitivity to vitamin B12, or to any other ingredient of the preparation. Bedodeka is not indicated for treatment of toxic amblyopias. Warnings An intradermal sensitivity test may be performed in patients with suspected hypersensitivity to cobalamins. It is important to accurately diagnose anemias prior to treatment, to ensure that appropriate therapy is initiated.
    [Show full text]
  • VITAMIN DEFICIENCIES in RELATION to the EYE* by MEKKI EL SHEIKH Sudan VITAMINS Are Essential Constituents Present in Minute Amounts in Natural Foods
    Br J Ophthalmol: first published as 10.1136/bjo.44.7.406 on 1 July 1960. Downloaded from Brit. J. Ophthal. (1960) 44, 406. VITAMIN DEFICIENCIES IN RELATION TO THE EYE* BY MEKKI EL SHEIKH Sudan VITAMINS are essential constituents present in minute amounts in natural foods. If these constituents are removed or deficient such foods are unable to support nutrition and symptoms of deficiency or actual disease develop. Although vitamins are unconnected with energy and protein supplies, yet they are necessary for complete normal metabolism. They are, however, not invariably present in the diet under all circumstances. Childhood and periods of growth, heavy work, childbirth, and lactation all demand the supply of more vitamins, and under these conditions signs of deficiency may be present, although the average intake is not altered. The criteria for the fairly accurate diagnosis of vitamin deficiencies are evidence of deficiency, presence of signs and symptoms, and improvement on supplying the deficient vitamin. It is easy to discover signs and symptoms of vitamin deficiencies, but it is not easy to tell that this or that vitamin is actually deficient in the diet of a certain individual, unless one is able to assess the exact daily intake of food, a process which is neither simple nor practical. Another way of approach is the assessment of the vitamin content in the blood or the measurement of the course of dark adaptation which demon- strates a real deficiency of vitamin A (Adler, 1953). Both tests entail more or less tedious laboratory work which is not easy in a provincial hospital.
    [Show full text]
  • VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Vitamin B12 Deficiency Can Have a Number of Possible
    VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Vitamin B12 deficiency can have a number of possible causes. Typically it occurs in people whose digestive systems do not adequately absorb the vitamin from the foods they eat. This can be caused by: Pernicious anemia, a condition in where there is a lack of a protein called intrinsic factor. The protein, which is made in the stomach, is necessary for vitamin B12 absorption. Other causes can be gastritis, surgery in which part of the stomach and/or small intestine is removed or conditions affecting the small intestine. Vitamin B12 deficiency can also occur in pregnancy and with long- term use of acid-reducing drugs. VI.2.2 Summary of treatment benefits A deficiency of vitamin B12 (cobalamin) is manifested by fatigue, weakness, mood fluctuations, memory loss, limb weakness, difficulty walking, tingling, and paralysis. Drug treatment involves the administration of vitamin B12 by injection. If the deficiency of vitamin B12 (cobalamin) depends on the underlying disease being resolved, the vitamin supplementation continues until normal levels of vitamin B12 are achieved. If the deficiency state cannot be resolved (e.g. inadequate secretion of intrinsic factor, genetic abnormalities related to the site absorption, etc.) therapy should be continued for life. VI.2.3 Unknowns relating to treatment benefits None. VI.2.4 Summary of safety concerns Risk What is known Preventability Damage to the optic nerve Optic nerve atrophy/blindness The product should be used (atrophy)/blindness in is a risk associated with with caution. patients with Leber´s disease treatment with (a disease that affects the hydroxocobalamin in patients optic nerve and often causes with Leber´s disease.
    [Show full text]
  • Vitamin B12 Deficiency ROBERT C
    Vitamin B12 Deficiency ROBERT C. OH, CPT, MC, USA, U.S. Army Health Clinic, Darmstadt, Germany DAVID L. BROWN, MAJ, MC, USA, Madigan Army Medical Center, Fort Lewis, Washington Vitamin B12 (cobalamin) deficiency is a common cause of macrocytic anemia and has been implicated in a spectrum of neuropsychiatric disorders. The role of B12 deficiency O A patient informa- in hyperhomocysteinemia and the promotion of atherosclerosis is only now being tion handout on vita- min B12 deficiency, explored. Diagnosis of vitamin B12 deficiency is typically based on measurement of written by the authors serum vitamin B12 levels; however, about 50 percent of patients with subclinical dis- of this article, is pro- ease have normal B12 levels. A more sensitive method of screening for vitamin B12 defi- vided on page 993. ciency is measurement of serum methylmalonic acid and homocysteine levels, which are increased early in vitamin B12 deficiency. Use of the Schilling test for detection of pernicious anemia has been supplanted for the most part by serologic testing for pari- etal cell and intrinsic factor antibodies. Contrary to prevailing medical practice, studies show that supplementation with oral vitamin B12 is a safe and effective treatment for the B12 deficiency state. Even when intrinsic factor is not present to aid in the absorp- tion of vitamin B12 (pernicious anemia) or in other diseases that affect the usual absorption sites in the terminal ileum, oral therapy remains effective. (Am Fam Physi- cian 2003;67:979-86,993-4. Copyright© 2003 American Academy of Family Physicians.) itamin B12 (cobalamin) plays manifestations (Table 1).It is a common cause an important role in DNA of macrocytic (megaloblastic) anemia and, in synthesis and neurologic func- advanced cases, pancytopenia.
    [Show full text]
  • Nutritional Dermatoses in the Hospitalized Patient
    HOSPITAL CONSULT IN PARTNERSHIP WITH THE SOCIETY FOR DERMATOLOGY HOSPITALISTS Nutritional Dermatoses in the Hospitalized Patient Melissa Hoffman, MS; Robert G. Micheletti, MD; Bridget E. Shields, MD Nutritional deficiencies may arise from inadequate nutrient intake, abnormal nutrient absorption, or improper nutrient PRACTICE POINTS utilization.4 Unfortunately, no standardized algorithm for • Nutritional deficiencies are common in hospitalized screening and diagnosing patients with malnutrition exists, patients and often go unrecognized. making early physical examination findings of utmost • Awareness of the risk factors predisposing patients importance. Herein, we present a review of acquired nutri- to nutritional deficiencies and the cutaneous manifes- tional deficiency dermatoses in the inpatient setting. tations associated with undernutrition can promote copy early diagnosis. Protein-Energy Malnutrition • When investigating cutaneous findings, undernutri- tion should be considered in patients with chronic Protein-energy malnutrition (PEM) refers to a set of infections, malabsorptive states, psychiatric illness, related disorders that include marasmus, kwashiorkor and strict dietary practices, as well as in those using (KW), and marasmic KW. These conditions frequently are certain medications. seen in developing countries but also have been reported 5 • Prompt nutritional supplementation can prevent patient in developed nations. Marasmus occurs from a chronic morbidity and mortality and reverse skin disease. deficiencynot of protein and calories. Decreased insulin pro- duction and unopposed catabolism result in sarcopenia and loss of bone and subcutaneous fat.6 Affected patients include children who are less than 60% ideal body weight Cutaneous disease may be the first manifestation of an underlying nutri- 7 tional deficiency, highlighting the importance of early recognition by der- (IBW) without edema or hypoproteinemia.
    [Show full text]
  • Vitamin B12 and Methylmalonic Acid Testing AHS – G2014
    Corporate Medical Policy Vitamin B12 and Methylmalonic Acid Testing AHS – G2014 File Name: vitamin_b12_and_methylmalonic_acid_testing Origination: 1/1/2019 Last CAP Review: 02/2021 Next CAP Review: 02/2022 Last Review: 02/2021 Description of Procedure or Service Vitamin B12, also known as cobalamin, is a water-soluble vitamin required for proper red blood cell formation, key metabolic processes, neurological function, and DNA regulation and synthesis. Hematologic and neuropsychiatric disorders caused by a deficiency in B12 can often be reversed by early diagnosis and prompt treatment (Oh & Brown, 2003). Methylmalonic acid is produced from excess methylmalonyl-CoA that accumulates when Vitamin B12 is unavailable and is considered an indicator of functional B12 deficiency (Sobczynska- Malefora et al., 2014). Holotranscobalamin (holoTC) is the metabolically active fraction of B12 and is an emerging marker of impaired vitamin B12 status (Langan & Goodbred, 2017). ***Note: This Medical Policy is complex and technical. For questions concerning the technical language and/or specific clinical indications for its use, please consult your physician. Policy BCBSNC will provide coverage for Vitamin B12 and Methylmalonic Acid Testing when it is determined the medical criteria or reimbursement guidelines below are met Benefits Application This medical policy relates only to the services or supplies described herein. Please refer to the Member's Benefit Booklet for availability of benefits. Member's benefits may vary according to benefit design; therefore member benefit language should be reviewed before applying the terms of this medical policy. When Vitamin B12 and Methylmalonic Acid Testing is covered 1. Reimbursement for vitamin B12 testing is allowed in individuals being evaluated for clinical manifestations of Vitamin B12 deficiency including: A.
    [Show full text]
  • Human Vitamin and Mineral Requirements
    Human Vitamin and Mineral Requirements Report of a joint FAO/WHO expert consultation Bangkok, Thailand Food and Agriculture Organization of the United Nations World Health Organization Food and Nutrition Division FAO Rome The designations employed and the presentation of material in this information product do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concern- ing the delimitation of its frontiers or boundaries. All rights reserved. Reproduction and dissemination of material in this information product for educational or other non-commercial purposes are authorized without any prior written permission from the copyright holders provided the source is fully acknowledged. Reproduction of material in this information product for resale or other commercial purposes is prohibited without written permission of the copyright holders. Applications for such permission should be addressed to the Chief, Publishing and Multimedia Service, Information Division, FAO, Viale delle Terme di Caracalla, 00100 Rome, Italy or by e-mail to [email protected] © FAO 2001 FAO/WHO expert consultation on human vitamin and mineral requirements iii Foreword he report of this joint FAO/WHO expert consultation on human vitamin and mineral requirements has been long in coming. The consultation was held in Bangkok in TSeptember 1998, and much of the delay in the publication of the report has been due to controversy related to final agreement about the recommendations for some of the micronutrients. A priori one would not anticipate that an evidence based process and a topic such as this is likely to be controversial.
    [Show full text]
  • Prevalence and Indicators of Vitamin B12 Insufficiency Among Young
    International Journal of Environmental Research and Public Health Article Prevalence and Indicators of Vitamin B12 Insufficiency among Young Women of Childbearing Age Sara Al-Musharaf 1,2,* , Philip G. McTernan 3,*, Syed Danish Hussain 2, Khalid Abdullah Aleisa 4 , Abdullah M. Alnaami 2, Kaiser Wani 2 , Ponnusamy Saravanan 5,6 and Nasser Al-Daghri 2 1 Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11451, Saudi Arabia 2 Chair for Biomarkers of Chronic Diseases, Riyadh Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia; [email protected] (S.D.H.); [email protected] (A.M.A.); [email protected] (K.W.); [email protected] (N.A.-D.) 3 Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham NG1 8NS, UK 4 College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia; [email protected] 5 Population, Evidence & Technologies, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry CV2 2DX, UK; [email protected] 6 Academic Department of Diabetes, Endocrinology & Metabolism, George Eliot Hospital, Nuneaton CV10 7DJ, UK * Correspondence: [email protected] (S.A.-M.); [email protected] (P.G.M.); Tel.: +44-(0)115-848-3477 (S.A.-M.); +966-55-424-3033 (P.G.M.) Abstract: Vitamin B12 insufficiency is a global health issue among women of childbearing age, yet few studies have investigated its prevalence and risk factors among healthy Middle Eastern populations. This cross-sectional study included 346 Saudi women aged 19–30 years and enrolled at King Saud University, Riyadh, Saudi Arabia.
    [Show full text]